Related Experiment Video
Updated: May 28, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS)
John Gallacher1, Peter Elwood, Janet Pickering
1Department of Primary Care and Public Health, Cardiff University, Cardiff, UK. gallacher@cf.ac.uk
Background:
Benzodiazepine use is widespread in older people, although its benefit is uncertain.
Aim:
To investigate the long-term effect of benzodiazepine use upon dementia risk.
Methods:
A prospective cohort of men seen on five occasions over 22 years with full medication histories, repeat measures of cognitive function and a clinical diagnosis of dementia.
Results:
Of 1134 men with complete data, 103 (9.1%) had been taking benzodiazepines regularly at one or more phases. These men showed a marked increased incidence of dementia (OR=3.50, 95% CI 1.57 to 7.79, p=0.002), which persisted despite adjustment for psychological distress and other covariates. Men exposed in earlier phases showed a greater association than more recent exposure, counter to what one would expect if this was due to reverse causation, though we failed to demonstrate a dose-response effect with drug duration.
Conclusion:
The taking of benzodiazepines is associated with an increased risk of dementia.
Related Concept Videos
Anxiolytic Drugs: Benzodiazepines and Buspirone
Pharmacodynamics in Geriatric Patients: Effects of Age
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Dementia
The progression of dementia is generally gradual.
Dementia l: Introduction
CNS Depressants: Barbiturates and Benzodiazepines
